Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Malignant Lymphoma

Free Subscription 16.07.2018 1 Am J Hematol 4 Blood 1 BMC Cancer 1 Br J Dermatol 7 Br J Haematol 2 Eur J Haematol 2 Haematologica 1 Int J Radiat Oncol Biol Phys 1 J Clin Oncol 3 Leuk Lymphoma 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Hematol

1. CASTILLO JJ, Beltran BE, Miranda RN, Young KH, et al
   EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management.
   Am J Hematol. 2018;93:953-962.
   PubMed     Text format     Abstract available
   
   

   
   Blood

2. GIULINO-ROTH L
   How I treat primary mediastinal B-cell lymphoma.
   Blood. 2018 Jul 5. pii: blood-2018-04-791566. doi: 10.1182/blood-2018-04-791566.
   PubMed     Text format     Abstract available
   
   
3. HOSER D, Schon C, Loddenkemper C, Lohneis P, et al
   Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice.
   Blood. 2018 Jul 12. pii: blood-2018-02-834036. doi: 10.1182/blood-2018-02-834036
   PubMed     Text format     Abstract available
   
   
4. ILLERHAUS G, Schorb E, Kasenda B
   Novel agents for primary central nervous system lymphoma (PCNSL): evidence and perspectives.
   Blood. 2018 Jul 9. pii: blood-2018-01-791558. doi: 10.1182/blood-2018-01-791558.
   PubMed     Text format     Abstract available
   
   
5. GORDON LI
   Getting to transplant in Hodgkin lymphoma: BVB.
   Blood. 2018;132:1-3.
   PubMed     Text format    
   
   

   
   BMC Cancer

6. KIM T, Choi HY, Lee HS, Jung SH, et al
   Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL).
   BMC Cancer. 2018;18:729.
   PubMed     Text format     Abstract available
   
   

   
   Br J Dermatol

7. GRIJSEN ML, Mtayangulwa RG, Naafs B, Jansen P, et al
   The clinical spectrum of mycosis fungoides in Tanzania, East-Africa.
   Br J Dermatol. 2016 Aug 16. doi: 10.1111/bjd.14963.
   PubMed     Text format     Abstract available
   
   

   
   Br J Haematol

8. CHIHARA D, Oki Y, Fanale MA, Westin JR, et al
   Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement.
   Br J Haematol. 2018 Jul 5. doi: 10.1111/bjh.15444.
   PubMed     Text format    
   
   
9. MONTALBAN C, Diaz-Lopez A, Martin A, Baile M, et al
   Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm.
   Br J Haematol. 2018 Jul 5. doi: 10.1111/bjh.15446.
   PubMed     Text format     Abstract available
   
   
10. EL-SHARKAWI D, Ng CH, Payne EM, Yong KL, et al
    Clinical outcomes and survival of patients with myeloma and lymphoma enrolled into phase I clinical trials.
    Br J Haematol. 2018 Jul 5. doi: 10.1111/bjh.15457.
    PubMed     Text format    
    
    
11. AILAWADHI S, Dholaria BR, Khurana S, Sher T, et al
    Outcomes of patients with simultaneous diagnosis of chronic lymphocytic leukaemia/small lymphocytic lymphoma and multiple myeloma.
    Br J Haematol. 2018 Jul 5. doi: 10.1111/bjh.15458.
    PubMed     Text format    
    
    
12. KHAN UT, Racu-Amoasii I, Arumainathan A, Meswani U, et al
    Central nervous system plasmablastic lymphoma evolving from polyclonal plasmacytosis.
    Br J Haematol. 2018 Jul 9. doi: 10.1111/bjh.15489.
    PubMed     Text format    
    
    
13. AVIVI I, Arcaini L, Ferretti VV, Boumendil A, et al
    High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO.
    Br J Haematol. 2018 Jul 9. doi: 10.1111/bjh.15454.
    PubMed     Text format     Abstract available
    
    
14. CAIRO M, Auperin A, Perkins SL, Pinkerton R, et al
    Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group.
    Br J Haematol. 2018 Jul 9. doi: 10.1111/bjh.15491.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Haematol

15. REPETTO-LLAMAZARES AHV, Malenge MM, O'Shea A, Eiriksdottir B, et al
    Combination of (177) Lu-lilotomab with rituximab significantly improves the therapeutic outcome in pre-clinical models of non-Hodgkin's lymphoma.
    Eur J Haematol. 2018 Jul 11. doi: 10.1111/ejh.13139.
    PubMed     Text format     Abstract available
    
    
16. SPUKTI EU, Schmidt LH, Schulze A, Schliemann C, et al
    (90) Y-ibritumomab-tiuxetan as a therapeutic alternative for Follicular lymphoma (FL): A single-center experience.
    Eur J Haematol. 2018 Jul 11. doi: 10.1111/ejh.13138.
    PubMed     Text format     Abstract available
    
    

    
    Haematologica

17. ARAF S, Wang J, Ashton-Key M, Korfi K, et al
    Transmission of diffuse large B cell lymphoma by an allogeneic stem-cell transplant.
    Haematologica. 2018 Jul 5. pii: haematol.2018.196907.
    PubMed     Text format    
    
    
18. VILLA D, Sehn LH, Aquino-Parsons C, Tonseth P, et al
    Interim PET-directed therapy in limited stage Hodgkin lymphoma initially treated with ABVD.
    Haematologica. 2018 Jul 12. pii: haematol.2018.196782.
    PubMed     Text format    
    
    

    
    Int J Radiat Oncol Biol Phys

19. TSANG RW, Campbell BA, Goda JS, Kelsey CR, et al
    Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2018;101:794-808.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

20. SASSE S, Goergen H, Plutschow A, Boll B, et al
    Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
    J Clin Oncol. 2018 Jul 10:JCO2018787192. doi: 10.1200/JCO.2018.78.7192.
    PubMed     Text format     Abstract available
    
    

    
    Leuk Lymphoma

21. WROBEL T, Biecek P, Rybka J, Szulgo A, et al
    Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group().
    Leuk Lymphoma. 2018 Jul 6:1-8. doi: 10.1080/10428194.2018.1482539.
    PubMed     Text format     Abstract available
    
    
22. LIM SW, Ryu KJ, Lee H, Ko YH, et al
    Serum IL18 is associated with hemophagocytosis and poor survival in extranodal natural killer/T-cell lymphoma.
    Leuk Lymphoma. 2018 Jul 6:1-9. doi: 10.1080/10428194.2018.1480772.
    PubMed     Text format     Abstract available
    
    
23. TANEJA A, Jones J, Pittaluga S, Maric I, et al
    Richter transformation to Hodgkin lymphoma on Bruton's tyrosine kinase inhibitor therapy.
    Leuk Lymphoma. 2018 Jul 6:1-4. doi: 10.1080/10428194.2018.1480775.
    PubMed     Text format    
    
    

    
    PLoS One

24. MUKHTAR F, Boffetta P, Dabo B, Park JY, et al
    Disparities by race, age, and sex in the improvement of survival for lymphoma: Findings from a population-based study.
    PLoS One. 2018;13:e0199745.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: